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BACKGROUND: We determined the association between various clinical parameters 
and significant liver injury in both hepatitis B e antigen (HBeAg)-positive and HBeAg-
negative patients. METHODS: From 1994 to 2008, liver biopsy was performed on 319 
treatment-naı v¨e CHB patients. Histologic assessment was based on the Knodell 
histologic activity index for necroinflammation and the Ishak fibrosis staging for fibrosis. 
Liver biochemistry, HBeAg status and HBV DNA levels were checked. RESULTS: 211 
HBeAg-positive and 108 HBeAg-negative patients were recruited, with a median age of 
31 and 46 years respectively. 9 out of 40 (22.5%) HBeAg-positive patients with normal 
ALT had significant histologic abnormalities (necroinflammation grading C7 or fibrosis 
score C3). There was a significant difference in fibrosis scores among HBeAg-positive 
patients with an ALT level within the Prati criteria (30 U/L for men, 19 U/L for women) 
and patients with a normal ALT but exceeding the Prati criteria (p = 0.024). Age, 
aspartate aminotransferase and platelet count were independent predictors of significant 
fibrosis in HBeAg-positive patients with an elevated ALT by multivariate analysis (p = 
0.007, 0.047 and 0.045 respectively). Serum HBV DNA and platelet count were 
predictors of significant fibrosis in HBeAg-negative disease (p = 0.020 and 0.015 
respectively). An elevated ALT was not predictive of significant fibrosis for both 
HBeAg-positive (p = 0.345) and –negative (p = 0.544) disease. There was no significant 
difference in fibrosis staging among ALT 1-2 x upper limit of normal (ULN) and [v2 
ULN for both HBeAg-positive (p = 0.098) and –negative (p = 0.838) disease. 
CONCLUSION: An elevated ALT does not accurately predict significant liver injury. 
Decisions on commencing antiviral therapy should not be heavily based on a particular 
ALT threshold. HBV DNA and platelet count are more important determinants of 
significance fibrosis in HBeAg-negative disease. 
